Kazia Therapeutics Ltd (ASX:KZA, NASDAQ: KZIA) CEO Dr James Garner speaks with Proactive after confirming a two-tranche capital raising initiative to raise A$4.5 million through placements to professional and sophisticated investors. The company's also offer eligible shareholders the opportunity to acquire up to A$30,000 of new shares through a share purchase plan.#ProactiveInvestors #KaziaTherapeutics #asx #pharma #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Contact Details

Proactive Investors

Jonathan Jackson

+61 413 713 744

Jonathan@proactiveinvestors.com